Evidence-based new service package vs. routine service package for smoking cessation to prevent high risk patients from cardiovascular diseases (CVD): study protocol for randomized controlled trial

Trials

Eiji Marui²  Somboon Chumvicharana^1,10  Yaoyanee Suya^1,10  Sachio Kawai¹  Payom Thinuan⁹  Prissana Naunboonruang⁹  Koichi Ono³  Yoshimune Hiratsuka^1,11  Susumu Tanimura⁸  Kazuo Minematsu⁷  Hirohide Yokokawa⁴  Tsutomu Kitajima⁶  Hiroshi Fukuda⁴  Saiyud Moolphate⁵  Thaworn Lorga⁹  Motoyuki Yuasa⁷  Myo Nyein Aung⁹ 

[1] Department of Sport Medicine, Juntendo University School of Health and Sport Science, Inba, Japan;Department of Human Arts Sciences, University of Human Arts and Sciences, Saitama, Japan;Department of Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan;Department of General Medicine, Juntendo University School of Medicine, Tokyo, Japan;Department of Public Health, Faculty of Science and Technology, Chiang Mai Rajabhat University, Chiang Mai, Thailand;Graduate School of International Cooperation Studies, Kyorin University, Hachioji, Japan;Department of Public Health, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan;Department of Public Health, Hyogo College of Medicine, Nishinomiya, Japan;Boromrajonani College of Nursing Nakhon Lampang (BCNLP), Lampang, Thailand;Maetha Hospital, Lampang, Thailand;Department of Health and Welfare Services, National Institute of Public Health, Wako, Japan

关键词: ESCAPE trial;    Tobacco;    Primary care;    CVD;    Lampang;    Thailand;    Family;    Smokerlyzer;    Smoking;   

Others  :  807839
DOI  :  10.1186/1745-6215-14-419

 received in 2013-09-05, accepted in 2013-11-21,  发布年份 2013

【 摘 要 】

Background

Smoking cessation is a high-priority intervention to prevent CVD events and deaths in developing countries. While several interventions to stop smoking have been proved successful, the question of how to increase their effectiveness and practicality in developing countries remains. In this study, a newly devised evidence-based smoking cessation service package will be compared with the existing service in a randomized controlled trial within the community setting of Thailand.

Method/Design

This randomized control trial will recruit 440 current smokers at CVD risk because of being diabetic and/or hypertensive. Informed, consented participants will be randomly allocated into the new service-package arm and the routine service arm. The study will take place in the non-communicable disease clinics of the Maetha District Hospital, Lampang, northern Thailand. The new smoking-cessation service-package comprises (1) regular patient motivation and coaching from the same primary care nurse over a 3-month period; (2) monthly application of piCO + smokerlyzer to sustain motivation of smoker’s quitting attempt and provide positive feedback over a 3-month period; (3) assistance by an assigned family member; (4) nicotine replacement chewing gum to relieve withdrawal symptoms. This new service will be compared with the traditional routine service comprising the 5A approach in a 1-year follow-up. Participants who consent to participate in the study but refuse to attempt quitting smoking will be allocated to the non-randomized arm, where they will be just followed up and monitored. Primary outcome of the study is smoking cessation rate at 1-year follow-up proven by breath analysis measuring carbomonoxide in parts per million in expired air. Secondary outcomes are smoking cessation rate at the 6-month follow-up, blood pressure and heart rate, CVD risk according to the Framingham general cardiovascular risk score, CVD events and deaths at the 12-month follow-up, and the cost-effectiveness of the health service packages. Intention-to-treat analysis will be followed. Factors influencing smoking cessation will be analyzed by the structure equation model.

Discussion

This multicomponent intervention, accessible at primary healthcare clinics, and focusing on the individual as well as the family and social environment, is unique and expected to work effectively.

Trial registration

Current Controlled Trials ISRCTN89315117

【 授权许可】

   
2013 Aung et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, et al.: Priority actions for the non-communicable disease crisis. Lancet 2011, 377(9775):1438-1447.
• [2]WHO: Cardiovascular disease. http://www.who.int/cardiovascular_diseases/en/ webcite
• [3]Bygbjerg IC: Double burden of noncommunicable and infectious diseases in developing countries. Science 2012, 337(6101):1499-1501.
• [4]World Hlealth Organization: Global health observatory (GHO). Risk Factors. http://www.who.int/gho/ncd/risk_factors/en/index.html webcite
• [5]Kamsa-ard S, Promthet S, Lewington S, Ann J, Burrett PS, Kamsa-ard S, Wiangnon S, Parkin DM: Association between smoking and mortality: Khon Kaen cohort study, Thailand. Asian Pac J Cancer Prev 2013, 14(4):2643-2647.
• [6]Benjakul S, Termsirikulchai L, Hsia J, Kengganpanich M, Puckcharern H, Touchchai C, Lohtongmongkol A, Andes L, Asma S: Current manufactured cigarette smoking and roll-your-own cigarette smoking in Thailand: findings from the 2009 global adult tobacco survey. BMC Public Health 2013, 13(1):277. BioMed Central Full Text
• [7]Aung MN, Lorga T, Srikrajang J, Promtingkran N, Kreuangchai S, Tonpanya W, Vivarakanon P, Jaiin P, Praipaksin N, Payaprom A: Assessing awareness and knowledge of hypertension in an at-risk population in the Karen ethnic rural community, Thasongyang, Thailand. Int J Gen Med 2012, 5:553-561.
• [8]Bureau of Health Policy and Strategy, Ministry of Public Health Thailand: Number of deaths and death rates per 100,000 population by leading causes of death, 2005–2009. http://bps.ops.moph.go.th/Statistic/2.3.4-52.pdf webcite
• [9]WHO: Situation of tobacco control in Thailand: national tobacco control policy. http://www.whothailand.org/en/Section3/Section104_306.htm webcite
• [10]Sangthong R, Wichaidit W, Ketchoo C: Current situation and future challenges of tobacco control policy in Thailand. Tob Control 2012, 21(1):49-54.
• [11]Abdullah ASM, Husten CG: Promotion of smoking cessation in developing countries: a framework for urgent public health interventions. Thorax 2004, 59(7):623-630.
• [12]Rungruanghiranya S, Ekpanyaskul C, Sakulisariyaporn C, Watcharanat P, Akkalakulawas K: Efficacy of fresh lime for smoking cessation. J Med Assoc Thai 2012, 95(12):S76-S82.
• [13]Papadakis S, McDonald P, Mullen K-A, Reid R, Skulsky K, Pipe A: Strategies to increase the delivery of smoking cessation treatments in primary care settings: a systematic review and meta-analysis. Prev Med 2010, 51(3–4):199-213.
• [14]ISRCTN89315117: Effective smoking cessation augmented PackagE (ESCAPE): evidence-based new service package vs. routine package to stop smoking. http://www.controlled-trials.com/ISRCTN89315117/ webcite
• [15]Efird J: Blocked randomization with randomly selected block sizes. Int J Environ Res Public Health 2011, 8(1):15-20.
• [16]Jelinek M, Vale MJ, Liew D, Grigg L, Dart A, Hare DL, Best JD: The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications—two years follow-up. Heart, Lung and Circulation 2009, 18(6):388-392.
• [17]Hughes JR: Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 2007, 9(3):315-327.
• [18]Ríos-Bedoya CF, Snedecor SM, Pomerleau CS, Pomerleau OF: Association of withdrawal features with nicotine dependence as measured by the Fagerström Test for nicotine dependence (FTND). Addict Behav 2008, 33(8):1086-1089.
• [19]Pumsawad V: Clinical Practice Guideline in Smoking Cessation (in Thai). Bangkok, Thailand: Thailand Ministry of Public Health; 2003.
• [20]Fagerstrom KO, Heatherton TF, Kozlowski L: Nicotine addiction and its assessment. Ear Nose Throat J 1990, 69(11):763-765.
• [21]Smokerlyzer:breath carbon monoxide (CO) monitor. http://www.bedfont.com/smokerlyzer webcite
• [22]Hald J, Overgaard J, Grau C: Evaluation of objective measures of smoking status–a prospective clinical study in a group of head and neck cancer patients treated with radiotherapy. Acta Oncol 2003, 42(2):154-159.
• [23]D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB: General cardiovascular risk profile for use in primary care. Circulation 2008, 117(6):743-753.
• [24]Framingham Heart Study: General cardiovascular disease (10 years risk): risk score calculators. http://www.framinghamheartstudy.org/risk-functions/cardiovascular-disease/10-year-risk.php webcite
• [25]Cahill LE, Chiuve SE, Mekary RA, Jensen MK, Flint AJ, Hu FB, Rimm EB: Prospective study of breakfast eating and incident coronary heart disease in a cohort of male US health professionals. Circulation 2013, 128(4):337-343.
• [26]World Health Organization: Waist circumference and waist-hip ratio: report of a WHO expert consultation. http://www.who.int/nutrition/publications/obesity/WHO_report_waistcircumference_and_waisthip_ratio/en/ webcite
• [27]West R: ABC of smoking cessation: assessment of dependence and motivation to stop smoking. BMJ: British Medical Journal 2004, 328(7435):338.
• [28]Kotz D, Brown J, West R: Predictive validity of the motivation to stop scale (MTSS): a single-item measure of motivation to stop smoking. Drug and Alcohol Dependence; 2012.
• [29]Ishikawa H, Nomura K, Sato M, Yano E: Developing a measure of communicative and critical health literacy: a pilot study of Japanese office workers. Health Promot Int 2008, 23(3):269-274.
• [30]Little RJ, D’Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Frangakis C, Hogan JW, Molenberghs G, Murphy SA, et al.: The prevention and treatment of missing data in clinical trials. N Engl J Med 2012, 367(14):1355-1360.
• [31]How physically active are you? An assessment of level and intensity of physical activity: university of Washington health promotion research center. http://depts.washington.edu/hprc/docs/rapa_03_06.pdf webcite
• [32]Cleophas TJ, Zwinderman AH: Clinical trials: how to assess confounding and why so. Curr Clin Pharmacol 2007, 2(2):129-133.
• [33]Furberg CD, Friedman LM: Approaches to data analyses of clinical trials. Progress in cardiovascular diseases 2012, 54(4):330-334.
• [34]McGough JJ, Faraone SV: Estimating the size of treatment effects: moving beyond p values. Psychiatry (Edgmont) 2009, 6(10):21-29.
• [35]Leartsakulpanitch J, Nganthavee W, Salole E: The economic burden of smoking-related disease in Thailand: a prevalence-based analysis. J Med Assoc Thai 2007, 90(9):1925-1929.
• [36]Bundhamcharoen K, Odton P, Phulkerd S, Tangcharoensathien V: Burden of disease in Thailand: changes in health gap between 1999 and 2004. BMC Public Health 2011, 11(1):53. BioMed Central Full Text
• [37]Rice Virginia H, Stead Lindsay F: Nursing interventions for smoking cessation. John Wiley & Sons, Ltd; 2008. [Cochrane database of systematic reviews]
• [38]Rigotti NA: Strategies to help a smoker who is struggling to quit. JAMA 2012, 308(15):1573-1580.
• [39]Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P: Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ (Clinical research ed) 2009, 338:b1024.
• [40]Okuyemi KS, Nollen NL, Ahluwalia JS: Interventions to facilitate smoking cessation. Am Fam Physician 2006, 74(2):262-271.
• [41]Yongchaiyud P, Kavita Tundulawessa B: The bioequivalent and effect of nicotine formulation gum on smoking cessation. J Med Assoc Thai 2010, 93(5):574-579.
• [42]Maneewan K, Silawan P, Kulsawet S, Thaworn L: Process of smoking cessation among Thai smokers: a grounded theory study. 2nd edition. Manila, Philippines; 2012. [International conference on qualitative research in nursing & health]
• [43]Lorga T, Suya Y, Meteechotset J: Family influence through negativity inflictions, suasion, and help (FINISH) for smoking cessation: a descriptive qualitative study. 2nd edition. Manila, Philippines; 2012. [International conference on qualitative research in nursing & health]
• [44]Murray RL, Bauld L, Hackshaw LE, McNeill A: Improving access to smoking cessation services for disadvantaged groups: a systematic review. J Public Health 2009, 31(2):258-277.
• [45]Hall S, Bishop AJ, Marteau TM: Increasing readiness to stop smoking in women undergoing cervical screening: evaluation of two leaflets. Nicotine Tob Res 2003, 5(6):821-826.